Evergreen Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$938K Buy
2,426
+1,305
+116% +$484K 0.02% 573
2026
Q1
$328K Buy
1,121
+13
+1% +$4.27K 0.01% 1059
2025
Q4
$388K Buy
1,108
+138
+14% +$46.6K 0.01% 891
2025
Q3
$313K Sell
970
-131
-12% -$40.7K 0.01% 935
2025
Q2
$428K Sell
1,101
-117
-10% -$47.1K 0.01% 631
2025
Q1
$530K Buy
1,218
+333
+38% +$134K 0.02% 485
2024
Q4
$326K Sell
885
-15,293
-95% -$6.4M 0.01% 689
2024
Q3
$8.41M Buy
16,178
+14,812
+1,084% +$7.91M 0.28% 100
2024
Q2
$740K Buy
1,366
+194
+17% +$103K 0.03% 362
2024
Q1
$608K Buy
1,172
+62
+6% +$30.8K 0.02% 398
2023
Q4
$523K Buy
1,110
+88
+9% +$40.7K 0.02% 413
2023
Q3
$445K Buy
1,022
+12
+1% +$5.44K 0.02% 423
2023
Q2
$449K Buy
1,010
+267
+36% +$123K 0.02% 418
2023
Q1
$342K Sell
743
-208
-22% -$99K 0.02% 472
2022
Q4
$488K Buy
951
+221
+30% +$112K 0.02% 376
2022
Q3
$332K Sell
730
-221
-23% -$106K 0.02% 424
2022
Q2
$459K Buy
951
+150
+19% +$74.2K 0.02% 352
2022
Q1
$393K Buy
801
+182
+29% +$83.2K 0.02% 421
2021
Q4
$287K Buy
619
+17
+3% +$7.15K 0.01% 490
2021
Q3
$224K Buy
602
+2
+0.3% +$760 0.01% 516
2021
Q2
$229K Sell
600
-35
-6% -$13.4K 0.01% 475
2021
Q1
$228K Buy
+635
New +$204K 0.01% 454
2020
Q1
Sell
-1,302
Closed -$393K 420
2019
Q4
$393K Buy
+1,302
New +$358K 0.03% 292
2019
Q3
Sell
-721
Closed -$203K 436
2019
Q2
$203K Buy
+721
New +$197K 0.02% 393

Other funds holding ELV

Evergreen Capital Management's ELV Position: Q2 2026 in Review

Evergreen Capital Management increased its Elevance Health (ELV) stake by 116% in Q2 2026, buying an estimated $484K and bringing the position to 2,426 shares worth $938K. The position accounts for 0.02% of the portfolio, ranked #573.

Evergreen Capital Management first reported a position in ELV in Q2 2019 and has held it in 24 quarters since. The position peaked at $8.41M in Q3 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Evergreen Capital Management held 2,426 shares of Elevance Health worth $938K as of Q2 2026.
  • Evergreen Capital Management bought 1,305 Elevance Health shares in Q2 2026, an estimated $484K.
  • Elevance Health made up 0.02% of Evergreen Capital Management's portfolio in Q2 2026, its #573 holding.
  • Evergreen Capital Management first reported a position in Elevance Health in Q2 2019 and has held it in 24 quarters since.
  • Evergreen Capital Management's Elevance Health position peaked at $8.41M in Q3 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.